BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1211 related articles for article (PubMed ID: 8637513)

  • 1. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
    Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
    Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
    Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
    N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC; Kodali VP; Silverman AL; Dmuchowski CF; Urdea MS; Chan CS; Wilber JC
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
    Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
    Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C in asymptomatic blood donors.
    Alter HJ; Conry-Cantilena C; Melpolder J; Tan D; Van Raden M; Herion D; Lau D; Hoofnagle JH
    Hepatology; 1997 Sep; 26(3 Suppl 1):29S-33S. PubMed ID: 9305660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
    Tullen E; De Saussure P; Soulier-Lauper M
    Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
    Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
    Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
    Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
    N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
    Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE
    Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and new hepatitis C virus infection after liver transplantation.
    Everhart JE; Wei Y; Eng H; Charlton MR; Persing DH; Wiesner RH; Germer JJ; Lake JR; Zetterman RK; Hoofnagle JH
    Hepatology; 1999 Apr; 29(4):1220-6. PubMed ID: 10094968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.